论文信息 - Fractionated Inotuzumab Ozogamicin Combined with Low-Intensity Chemotherapy in Older Patients with Newly Diagnosed CD22+ Philadelphia Chromosome (Ph)-Negative B-Cell Precursor (BCP) Acute Lymphoblastic Leukemia (ALL): Results of the EWALL-INO Study - 字舞流文

Fractionated Inotuzumab Ozogamicin Combined with Low-Intensity Chemotherapy in Older Patients with Newly Diagnosed CD22+ Philadelphia Chromosome (Ph)-Negative B-Cell Precursor (BCP) Acute Lymphoblastic Leukemia (ALL): Results of the EWALL-INO Study

E. Clappier | H. Dombret | S. Leprêtre | P. Chevallier | T. Cluzeau | C. Gardin | P. Rousselot | N. Boissel | M. Delord | E. Raffoux | M. Doubek | C. Saillard | F. Huguet | M. Balsat | U. Wartiovaara-Kautto | T. Leguay | A. Cabannes-Hamy | R. Kim | A. Berceanu